Mid-Term and Long-Term Impact of Permanent Hypoparathyroidism After Total Thyroidectomy. 2020

Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
Service of Endocrine and Advanced Laparoscopic Surgery/Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Vasco de Quiroga 15, Seccion XVI, Tlalpan, 14000, Mexico City, Mexico.

Permanent hypoparathyroidism (PH) is the most frequent long-term complication after total thyroidectomy. PH is related to many short-term and long-term complications, including clinical manifestations of hypocalcemia, hypercalcemia due to overtreatment, hyperphosphatemia, gastrointestinal, neuropsychiatric symptoms, decrease in renal function and infectious complications. The aim of this study was to identify the most frequent effects of PH and its associated risk factors. We performed a retrospective analysis of a single institutional series of patients who developed PH after total thyroidectomy between 2000 and 2016. PH was defined as hypoparathormonemia (≤12 pg/mL) or the need for calcium/vitamin D supplementation to achieve normal calcium levels for more than 12 months. Descriptive and inferential statistics were employed based on the natural scaling of each included variable. Thirty-nine patients fulfilled the criteria for PH. Mean ± SD age was 46.26 ± 13.4 years; 6 (15.4%) were males and 33 (84.6%) females. Mean follow-up was 6.13 ± 3.25 years. Mean calcium carbonate supplementation doses per day were 18.95 ± 17.5 g and 21.4 ± 19.3 g at 1 year and last follow-up, respectively. Hypocalcemic crisis was the most common complication (66.7%), followed by neuropsychiatric (38.5%) and gastrointestinal symptoms (33.3%). Ten patients showed a decrease in renal function (eGFR drop ≥25%) and 4 developed chronic kidney disease. The amount of calcium supplementation was the most relevant related risk factor. PH is associated with multiple complications, including renal function impairment, gastrointestinal, neuropsychiatric and infectious complications. Lower calcium supplementation doses are related to lower complications rates.

UI MeSH Term Description Entries
D006996 Hypocalcemia Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed) Hypocalcemias
D007011 Hypoparathyroidism A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone. Idiopathic Hypoparathyroidism,Hypoparathyroidism, Idiopathic
D007239 Infections Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases. Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D007508 Irritable Mood Abnormal or excessive excitability with easily triggered anger, annoyance, or impatience. Mood, Irritable,Irritable Moods,Moods, Irritable
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002119 Calcium Carbonate Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement. Aragonite,Calcite,Chalk,Limestone,Marble,Milk of Calcium,Vaterite,Calcium Milk,Carbonate, Calcium
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas

Related Publications

Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
October 2014, World journal of surgery,
Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
July 2015, Thyroid : official journal of the American Thyroid Association,
Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
February 2021, Journal of clinical medicine,
Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
September 2018, The British journal of surgery,
Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
January 2020, Surgery,
Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
October 2007, Minerva chirurgica,
Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
December 2017, Gland surgery,
Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
March 2018, ANZ journal of surgery,
Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
September 2018, World journal of surgery,
Guillermo Ponce de León-Ballesteros, and Carlos Bonilla-Ramírez, and Francisco Javier Hernández-Calderón, and Juan Pablo Pantoja-Millán, and Mauricio Sierra-Salazar, and David Velázquez-Fernández, and Miguel F Herrera
April 2016, Head & neck,
Copied contents to your clipboard!